Form 4: Thermo Fisher CEO Disposes Shares for Tax Obligations

Thermo Fisher Scientific's Chairman and CEO, Marc N. Casper, reported the disposition of common stock to cover tax liabilities.

Summary

• Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific Inc. (TMO), reported two dispositions of common stock on August 28, 2025.
• The transactions involved the disposition of 686.571 shares and 724.767 shares, both at a price of $489.74 per share.
• These dispositions, totaling 1,411.338 shares, were made to satisfy tax obligations, indicated by transaction code 'F'.
• Following these transactions, Mr. Casper directly beneficially owns 113,762.285 shares of common stock.
• He also indirectly beneficially owns 11,300 shares through the Alison Casper 2020 Irrevocable Trust, 14,608 shares through Floral Park Associates, Inc., and 5,000 shares through the MNC 2020 Irrevocable Trust, disclaiming beneficial ownership except for pecuniary interest in the trust holdings.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the reported transactions are routine dispositions of common stock to cover tax obligations, which is a standard practice for executives and not indicative of a change in company outlook or performance.

Positives

• The transactions were executed under a Rule 10b5-1(c) pre-arranged plan, indicating a scheduled, non-discretionary disposition.
• Marc N. Casper retains a substantial direct and indirect beneficial ownership in the company, aligning his interests with shareholders.

Negatives

• The direct beneficial ownership of common stock by the Chairman and CEO decreased by 1,411.338 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitors.

Related Party Transactions

• Marc N. Casper indirectly holds shares through the Alison Casper 2020 Irrevocable Trust and the MNC 2020 Irrevocable Trust, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.
• He also indirectly holds shares through Floral Park Associates, Inc.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, pre-planned tax-related disposition by an executive, not signaling a change in confidence or company fundamentals.

Key Dates

Recommendation

The reported transactions are routine dispositions of common stock by the CEO to cover tax obligations, executed under a pre-arranged 10b5-1 plan. Such transactions are common for executives and do not typically signal a change in the company's fundamental value or future prospects, thus providing no strong basis for a buy or sell recommendation. A 'hold' recommendation is appropriate as this filing does not present new information to alter an existing investment thesis.

Keywords

Thermo Fisher Scientific, TMO, Marc N. Casper, Insider Transaction, Form 4, Stock Disposition, CEO, Director, Tax Liability